Temporal Response Characterization Across Individual Multiomics Profiles of Prediabetic and Diabetic Subjects

Overview

Journal Sci Rep

Specialty Science

Date 2022 Jul 15

PMID 35840765

Authors

Minzhang Zheng

Carlo Piermarocchi

George I Mias

Affiliations

Soon will be listed here.

Abstract

Longitudinal deep multiomics profiling, which combines biomolecular, physiological, environmental and clinical measures data, shows great promise for precision health. However, integrating and understanding the complexity of such data remains a big challenge. Here we utilize an individual-focused bottom-up approach aimed at first assessing single individuals' multiomics time series, and using the individual-level responses to assess multi-individual grouping based directly on similarity of their longitudinal deep multiomics profiles. We used this individual-focused approach to analyze profiles from a study profiling longitudinal responses in type 2 diabetes mellitus. After generating periodograms for individual subject omics signals, we constructed within-person omics networks and analyzed personal-level immune changes. The results identified both individual-level responses to immune perturbation, and the clusters of individuals that have similar behaviors in immune response and which were associated to measures of their diabetic status.

Citing Articles

Application of Clinical Blood Metabogram to Type 2 Diabetes Mellitus.

Lokhov P, Balashova E, Trifonova O, Maslov D, Shestakova E, Shestakova M Metabolites. 2024; 14(3).

PMID: 38535328 PMC: 10972189. DOI: 10.3390/metabo14030168.

Time-resolved molecular measurements reveal changes in astronauts during spaceflight.

Zheng M, Charvat J, Zwart S, Mehta S, Crucian B, Smith S Front Physiol. 2023; 14:1219221.

PMID: 37520819 PMC: 10376710. DOI: 10.3389/fphys.2023.1219221.

Clinical Blood Metabogram: Application to Overweight and Obese Patients.

Lokhov P, Balashova E, Trifonova O, Maslov D, Plotnikova O, Sharafetdinov K Metabolites. 2023; 13(7).

PMID: 37512504 PMC: 10386708. DOI: 10.3390/metabo13070798.

Current State and Future Perspectives on Personalized Metabolomics.

Trifonova O, Maslov D, Balashova E, Lokhov P Metabolites. 2023; 13(1).

PMID: 36676992 PMC: 9863827. DOI: 10.3390/metabo13010067.

References

Mias G, Yusufaly T, Roushangar R, Brooks L, Singh V, Christou C . MathIOmica: An Integrative Platform for Dynamic Omics. Sci Rep. 2016; 6:37237. PMC: 5121649. DOI: 10.1038/srep37237. View

Vargas-Alarcon G, Perez-Hernandez N, Rodriguez-Perez J, Fragoso J, Posadas-Romero C, Lopez-Bautista F . Interleukin 27 polymorphisms, their association with insulin resistance and their contribution to subclinical atherosclerosis. The GEA Mexican study. Cytokine. 2018; 114:32-37. DOI: 10.1016/j.cyto.2018.11.028. View

Schussler-Fiorenza Rose S, Contrepois K, Moneghetti K, Zhou W, Mishra T, Mataraso S . A longitudinal big data approach for precision health. Nat Med. 2019; 25(5):792-804. PMC: 6713274. DOI: 10.1038/s41591-019-0414-6. View

Randeria S, Thomson G, Nell T, Roberts T, Pretorius E . Inflammatory cytokines in type 2 diabetes mellitus as facilitators of hypercoagulation and abnormal clot formation. Cardiovasc Diabetol. 2019; 18(1):72. PMC: 6549308. DOI: 10.1186/s12933-019-0870-9. View

Kellogg R, Dunn J, Snyder M . Personal Omics for Precision Health. Circ Res. 2018; 122(9):1169-1171. DOI: 10.1161/CIRCRESAHA.117.310909. View

Seijkens T, Kusters P, Engel D, Lutgens E . CD40-CD40L: linking pancreatic, adipose tissue and vascular inflammation in type 2 diabetes and its complications. Diab Vasc Dis Res. 2012; 10(2):115-22. DOI: 10.1177/1479164112455817. View

Wang R, Han G, Wang J, Chen G, Xu R, Wang L . The pathogenic role of interleukin-27 in autoimmune diabetes. Cell Mol Life Sci. 2008; 65(23):3851-60. PMC: 11131745. DOI: 10.1007/s00018-008-8540-1. View

So B, Song Y, Fang C, Park J, Lee Y, Shin J . G-CSF prevents progression of diabetic nephropathy in rat. PLoS One. 2013; 8(10):e77048. PMC: 3805566. DOI: 10.1371/journal.pone.0077048. View

Herder C, Baumert J, Thorand B, Koenig W, de Jager W, Meisinger C . Chemokines as risk factors for type 2 diabetes: results from the MONICA/KORA Augsburg study, 1984-2002. Diabetologia. 2006; 49(5):921-9. DOI: 10.1007/s00125-006-0190-y. View

10.

Higurashi M, Ohya Y, Joh K, Muraguchi M, Nishimura M, Terawaki H . Increased urinary levels of CXCL5, CXCL8 and CXCL9 in patients with Type 2 diabetic nephropathy. J Diabetes Complications. 2008; 23(3):178-84. DOI: 10.1016/j.jdiacomp.2007.12.001. View

11.

Hasin Y, Seldin M, Lusis A . Multi-omics approaches to disease. Genome Biol. 2017; 18(1):83. PMC: 5418815. DOI: 10.1186/s13059-017-1215-1. View

12.

Mou X, Zhou D, Zhou D, Ma J, Liu Y, Chen H . Serum TGF-β1 as a Biomarker for Type 2 Diabetic Nephropathy: A Meta-Analysis of Randomized Controlled Trials. PLoS One. 2016; 11(2):e0149513. PMC: 4764759. DOI: 10.1371/journal.pone.0149513. View

13.

Yeboah J, Sane D, Crouse J, Herrington D, Bowden D . Low plasma levels of FGF-2 and PDGF-BB are associated with cardiovascular events in type II diabetes mellitus (diabetes heart study). Dis Markers. 2007; 23(3):173-8. PMC: 3851608. DOI: 10.1155/2007/962892. View

14.

Mias G, Singh V, Rogers L, Xue S, Zheng M, Domanskyi S . Longitudinal saliva omics responses to immune perturbation: a case study. Sci Rep. 2021; 11(1):710. PMC: 7804305. DOI: 10.1038/s41598-020-80605-6. View

15.

Gambhir S, Ge T, Vermesh O, Spitler R . Toward achieving precision health. Sci Transl Med. 2018; 10(430). PMC: 5985668. DOI: 10.1126/scitranslmed.aao3612. View

16.

Miranda T, Heluy S, Cruz D, da Silva H, Feres M, Figueiredo L . The ratios of pro-inflammatory to anti-inflammatory cytokines in the serum of chronic periodontitis patients with and without type 2 diabetes and/or smoking habit. Clin Oral Investig. 2018; 23(2):641-650. DOI: 10.1007/s00784-018-2471-5. View

17.

Tasaki S, Suzuki K, Kassai Y, Takeshita M, Murota A, Kondo Y . Multi-omics monitoring of drug response in rheumatoid arthritis in pursuit of molecular remission. Nat Commun. 2018; 9(1):2755. PMC: 6048065. DOI: 10.1038/s41467-018-05044-4. View

18.

Qiao Y, Chen Y, Pan Y, Ling W, Tian F, Zhang X . Changes of transforming growth factor beta 1 in patients with type 2 diabetes and diabetic nephropathy: A PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore). 2017; 96(15):e6583. PMC: 5403085. DOI: 10.1097/MD.0000000000006583. View

19.

Fay M, Proschan M . Wilcoxon-Mann-Whitney or t-test? On assumptions for hypothesis tests and multiple interpretations of decision rules. Stat Surv. 2010; 4:1-39. PMC: 2857732. DOI: 10.1214/09-SS051. View

20.

Croft D, OKelly G, Wu G, Haw R, Gillespie M, Matthews L . Reactome: a database of reactions, pathways and biological processes. Nucleic Acids Res. 2010; 39(Database issue):D691-7. PMC: 3013646. DOI: 10.1093/nar/gkq1018. View